A new study led by Zafar Zafari, MSc, PhD, assistant professor in the Department of Pharmaceutical Health Services Research (PHSR) at the University of Maryland School of Pharmacy, offers projected estimates of the health and economic burden associated with chronic obstructive pulmonary disease (COPD) in the U.S. over the next 20 years. Published in CHEST, the study titled “Projecting Long-Term Health and Economic Burden of Chronic Obstructive Pulmonary Disease in the United States,” provides critical data that policymakers can use to inform key decisions that may help mitigate these costs over time.